Skip to content

DR. CLAESSENS LUCAS

Active
Private limited companyfounded 2023active for 2 yearsOude Ophoverbaan 160, 3680 Maaseik, BelgiumKBO/BCE: BE 1002.596.057

From the official registers: KBO 2 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. CLAESSENS LUCAS has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €131,247 and a net result of €70,620. Its solvency ranks better than 69% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 23-11-2023 Normal situation
Legal form
Private limited company
Registered office
Oude Ophoverbaan 160, 3680 Maaseik
Activity
General medical practice NACE 86210
Establishment unit
2.352.379.365 3680 Maaseik, since 23-11-2023
Financial year end
31 December
Peppol
Reachable since 02-09-2025

Board and ownership

Board
  • Claessens LucasDirector · since 23-11-2023

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€100,429
▲ 21.0%
Turnover
≈ €180,000
estimated
Profit
€70,620
▲ 22.5%
Equity
€131,247
▲ 116%
Total assets
€164,964
▲ 75.3%
2025 accounts filed 17 days before the deadline
Filed on 14-07-2026at the National Bank
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 9.95, cash €119,205Equity €131,247 (79.6% of total assets)Size: total assets €164,964Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 87% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+11
equity 79.6% of total assets
Liquidity 100+1
short-term debt 8.2% · cash 72.3%
Profitability 100=
return on assets 42.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.4%▲ +0.1 percentage points vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.4 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €12,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 9.95 (5.27 in 2024), above the usual 1.5. Short-term debt is 8.2% and cash 72.3% of total assets. 20.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 80% on profitability and 91% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 9.95, cash €119,205
NBB · annual accounts
lowers risk · Equity €131,247 (79.6% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €164,964
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Young company
Founded in 2023, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-07-2026, 17 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
17 days early
2024
3 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 10 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Key points

  • Positive: Equity rose in 2025from €60,627 to €131,247 ▲ 116% View

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about DR. CLAESSENS LUCAS

What is the company number of DR. CLAESSENS LUCAS?
The company number of DR. CLAESSENS LUCAS is 1002.596.057. The VAT number is the same number with BE in front: BE 1002.596.057.
Where is DR. CLAESSENS LUCAS based?
The registered office is at Oude Ophoverbaan 160, 3680 Maaseik.Company details
What does DR. CLAESSENS LUCAS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. CLAESSENS LUCAS?
The legal form of DR. CLAESSENS LUCAS is Private limited company (BV).
When was DR. CLAESSENS LUCAS founded?
DR. CLAESSENS LUCAS was founded on 23-11-2023.
Is DR. CLAESSENS LUCAS still active?
Yes, DR. CLAESSENS LUCAS is an active enterprise in the KBO register.
What is the turnover of DR. CLAESSENS LUCAS?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €100,429 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €230,000.Financials
Is DR. CLAESSENS LUCAS profitable?
In financial year 2025, DR. CLAESSENS LUCAS made a profit of €70,620.
Where can I find the annual accounts of DR. CLAESSENS LUCAS?
DR. CLAESSENS LUCAS filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR. CLAESSENS LUCAS due?
DR. CLAESSENS LUCAS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as DR. CLAESSENS LUCAS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €158,000 and €184,000, founded between 2023 and 2024.

CompanyTotal assetsGross margin
DR. CLAESSENS LUCAS Maaseik€164,964€100,429
Amar Huisarts Sint-Truiden€158,284€96,962
Dokter Germeys Tom Genk€174,870€109,196
DR JAN BEHETS Tessenderlo-Ham€183,944€106,436
RLG Med Anderlecht€163,393€100,632
Dr. Anass El Malahi Boom€166,786€99,226
Dokter Sien Van Herck Mechelen€160,284€103,026
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.